Mayinglong Pharmaceutical Group Co Ltd (600993) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Based on the latest financial reports, Mayinglong Pharmaceutical Group Co Ltd (600993) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.20 Million ≈ $20.37 Million USD) by net assets (CN¥4.43 Billion ≈ $648.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Mayinglong Pharmaceutical Group Co Ltd's balance sheet to measure how much of total assets are equity-financed.

Mayinglong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Mayinglong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Mayinglong Pharmaceutical Group Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Mayinglong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mayinglong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DOMS Industries Limited NSE:DOMS	0.046x
E-Mart KO:139480	0.069x
Meridianlink Inc NYSE:MLNK	0.049x
Nusantara Sawit Sejahtera JK:NSSS	0.079x
Sociedad Matriz SAAM SA SN:SMSAAM	-0.031x
Métropole Télévision S.A. PA:MMT	0.037x
Northking Information Technology Co SHE:002987	0.027x
Aryzta AG SW:ARYN	0.302x

Annual Cash Flow Conversion Efficiency for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Mayinglong Pharmaceutical Group Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.51 Billion ≈ $660.65 Million	CN¥600.44 Million ≈ $87.86 Million	0.133x	+12.29%
2024-12-31	CN¥4.20 Billion ≈ $614.78 Million	CN¥497.61 Million ≈ $72.82 Million	0.118x	-24.12%
2023-12-31	CN¥3.87 Billion ≈ $566.29 Million	CN¥604.07 Million ≈ $88.39 Million	0.156x	+65.24%
2022-12-31	CN¥3.62 Billion ≈ $529.55 Million	CN¥341.85 Million ≈ $50.02 Million	0.094x	-47.57%
2021-12-31	CN¥3.31 Billion ≈ $484.97 Million	CN¥597.17 Million ≈ $87.38 Million	0.180x	+87.62%
2020-12-31	CN¥2.95 Billion ≈ $431.18 Million	CN¥282.99 Million ≈ $41.41 Million	0.096x	-48.52%
2019-12-31	CN¥2.63 Billion ≈ $385.58 Million	CN¥491.58 Million ≈ $71.93 Million	0.187x	+42.35%
2018-12-31	CN¥2.35 Billion ≈ $344.15 Million	CN¥308.24 Million ≈ $45.11 Million	0.131x	-16.43%
2017-12-31	CN¥2.27 Billion ≈ $332.31 Million	CN¥356.17 Million ≈ $52.12 Million	0.157x	+32.02%
2016-12-31	CN¥2.02 Billion ≈ $295.13 Million	CN¥239.60 Million ≈ $35.06 Million	0.119x	+22.57%
2015-12-31	CN¥1.89 Billion ≈ $276.06 Million	CN¥182.85 Million ≈ $26.76 Million	0.097x	+47.44%
2014-12-31	CN¥1.70 Billion ≈ $248.58 Million	CN¥111.67 Million ≈ $16.34 Million	0.066x	-20.76%
2013-12-31	CN¥1.57 Billion ≈ $229.19 Million	CN¥129.94 Million ≈ $19.01 Million	0.083x	-29.74%
2012-12-31	CN¥1.43 Billion ≈ $209.74 Million	CN¥169.25 Million ≈ $24.77 Million	0.118x	+106.81%
2011-12-31	CN¥1.32 Billion ≈ $193.15 Million	CN¥75.37 Million ≈ $11.03 Million	0.057x	+663.58%
2010-12-31	CN¥1.13 Billion ≈ $164.95 Million	CN¥-11.42 Million ≈ $-1.67 Million	-0.010x	-104.93%
2009-12-31	CN¥1.05 Billion ≈ $153.90 Million	CN¥216.11 Million ≈ $31.62 Million	0.205x	+74.55%
2008-12-31	CN¥871.43 Million ≈ $127.52 Million	CN¥102.59 Million ≈ $15.01 Million	0.118x	+1448.66%
2007-12-31	CN¥853.12 Million ≈ $124.84 Million	CN¥6.49 Million ≈ $948.97K	0.008x	-91.36%
2006-12-31	CN¥855.21 Million ≈ $125.14 Million	CN¥75.27 Million ≈ $11.01 Million	0.088x	-10.15%
2005-12-31	CN¥596.55 Million ≈ $87.29 Million	CN¥58.43 Million ≈ $8.55 Million	0.098x	-0.19%
2004-12-31	CN¥552.20 Million ≈ $80.80 Million	CN¥54.19 Million ≈ $7.93 Million	0.098x	-66.37%
2003-12-31	CN¥231.35 Million ≈ $33.85 Million	CN¥67.52 Million ≈ $9.88 Million	0.292x	--

About Mayinglong Pharmaceutical Group Co Ltd

SHG:600993 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.48 Billion

CN¥10.10 Billion CNY

Market Cap Rank

#7256 Global

#1562 in China

Share Price

CN¥23.42

Change (1 day)

-0.85%

52-Week Range

CN¥21.55 - CN¥30.12

All Time High

CN¥31.68